These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3709621)

  • 21. [Sacroradiculo graphic and myelographic investigations with iopamidol: study of 610 examinations (author's transl)].
    Caputo N; Chiurulla C; Cianciulli E; Ciorba E; Floridi P; Pelliccioli GP; Capponi O; Signorini E
    Riv Patol Nerv Ment; 1981; 102(2):56-68. PubMed ID: 7345552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines for cervical myelography: lumbar versus cervical puncture technique.
    Teasdale E; Macpherson P
    Br J Radiol; 1984 Sep; 57(682):789-93. PubMed ID: 6478137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Iotrol, a new myelographic agent: 1. Radiography, CT, CSF clearance, and brain penetration.
    Kerber CW; Sovak M; Ranganathan RS; Heilman CB
    AJNR Am J Neuroradiol; 1983; 4(3):317-8. PubMed ID: 6410732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse side effects of metrizamide and iopamidolo in myelography.
    Carella A; Federico F; Di Cuonzo F; Vinjau E; Lamberti P
    Neuroradiology; 1982; 22(5):247-9. PubMed ID: 6174896
    [No Abstract]   [Full Text] [Related]  

  • 25. [Iopamidol: a complementary study in 42 patients with pathology indicating the need for myeloradiculography].
    Fredy D
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):793-6. PubMed ID: 6670842
    [No Abstract]   [Full Text] [Related]  

  • 26. [1st trials of a new contrast medium, iopamidol, in the study of the spinal canal].
    Bories J; Chiras J; Drouineau J
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):789-92. PubMed ID: 6670841
    [No Abstract]   [Full Text] [Related]  

  • 27. [Neuroradiological experiences iopamidol, a new non-ionic hydro-soluble contrast medium. Comparison to metrizamide with special considerations of side effects and pharmacodynamics with regard to clinical use (author's transl)].
    Hammer B
    Radiologe; 1981 Jun; 21(6):274-81. PubMed ID: 6973775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical myelography with iopamidolo.
    Belloni G; Bonaldi G; Moschini L; Quilici N
    Neuroradiology; 1981 Mar; 21(2):97-9. PubMed ID: 7207817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excitation and depression of non-anaesthetized rabbits following injection of contrast media into the subarachnoid space.
    Golman K; Olivecrona H; Gustafson C; Salvesen S; Almén T; Maly P
    Acta Radiol Suppl; 1980; 362():83-6. PubMed ID: 6267897
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse reaction to iopamidol.
    Robinson C; Fon G
    Med J Aust; 1986 May; 144(10):553. PubMed ID: 3713572
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of myelographic contrast-medium tolerance with psychometric testing.
    Hammeke TA; Grogan JP; Haughton VM; Pfeiffer MM; Harrington GJ; Sudilovsky A
    AJNR Am J Neuroradiol; 1985; 6(3):343-8. PubMed ID: 3923791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iopamidol for myelography. A clinical trial with a new non-ionic contrast medium.
    Peeters F; van Dongen K; Hekster R; Hoogland P; Thijssen H; Tjian T; Wilmink J; Althuisius H
    Diagn Imaging; 1983; 52(6):313-5. PubMed ID: 6357678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotoxicity of nonionic iodinated water-soluble contrast media in myelography: experimental study.
    Caillé JM; Gioux M; Arné P; Paty J
    AJNR Am J Neuroradiol; 1983; 4(6):1185-9. PubMed ID: 6419559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dynamic CT examination with iopamidol].
    Ishiguchi T; Sakuma S
    Rinsho Hoshasen; 1985 Apr; 30(4):531-2. PubMed ID: 4021153
    [No Abstract]   [Full Text] [Related]  

  • 35. Contrast media and bronchospasm: a study with iopamidol.
    Dawson P; Pitfield J; Britton J
    Clin Radiol; 1983 Mar; 34(2):227-30. PubMed ID: 6825405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iopamidol (B 15,000), a nonionic water-soluble contrast medium for neuroradiology. part II: results of a double-blind study of the lumbar epidural venous plexuses.
    Bacarini L; de Nicola T; Gasparini D; Orlando P; Vassallo A
    Neuroradiology; 1982; 23(3):147-52. PubMed ID: 6211636
    [No Abstract]   [Full Text] [Related]  

  • 37. Iopamidol for myelography--practical implications.
    de Villiers PD; Snyman PJ; van Rensburg MN; Lamprecht DS; Greeff GP
    S Afr Med J; 1984 Nov; 66(18):697-8. PubMed ID: 6495113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of iopamidol for angiocardiography in infants under 7 kilograms. Preliminary report apropos of 9 cases].
    Grumbach Y; Maingourd Y; Dieval M; Risbourg B
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):714-5. PubMed ID: 6670827
    [No Abstract]   [Full Text] [Related]  

  • 39. The symptomatic complications of iopamidol (Niopam) and metrizamide (Amipaque) following lumbar radiculography.
    Stoddart PG; Watt I
    Br J Radiol; 1984 Apr; 57(676):349-50. PubMed ID: 6704672
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of iopamidol with three other contrast media in orbital venography/cavernous sinography.
    Macpherson P
    Br J Radiol; 1982 Jul; 55(655):539-40. PubMed ID: 7150905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.